Health Protection & Promotion for Oregon Correctional Officers (DOC HEALTH)

October 28, 2015 updated by: Kerry Kuehl, Oregon Health and Science University
More than 530,000 individuals work as US Correctional Officers (COs) responsible for overseeing the approximately 1.6 million offenders who are incarcerated at any given time in the United States. Prison work is regarded as one of the most difficult occupations with CO's having one of the highest nonfatal injury rates of all U.S. occupations. The few studies done on CO's show high levels of stress, cardiovascular disease, high job burnout, increased sick leave rates and absenteeism, and decreased quality of life leading to premature illness/injury and high employer healthcare costs. Many of these conditions could be prevented by specific training activities and healthier lifestyles. The investigators wish to test a worksite-based, health promotion curriculum in COs with the overall hypothesis that the program will improve health and decrease injuries. The program proposed would be the first occupational intervention to improve the safety, and emotional and physical health of those who are charged with the complex task of prison work protecting the investigators communities. If successful, this proposal would result in an exportable, practical occupational safety and health program applicable for use by local, state, and federal correctional facilities.

Study Overview

Detailed Description

Investigators will enroll up to 100 Correctional Officers from four Oregon Department of Corrections facilities for a randomized controlled 1-year assessment of the intervention. Participants will be evaluated at baseline, 6, and 12 months.

Primary study aims are; 1) Implement a randomized controlled efficacy trial of the Team-centered health promotion intervention, and assess its behavioral and occupational outcomes among COs, 2) Perform a cost analysis to determine the potential economic impact of this CO worksite health promotion program on illness/injury rates and disability claims, and 3) Determine relationships among specific intervention components with changes to behavior and occupational outcomes and assess by mediation analysis.

The intervention involves a scripted peer-taught interactive curriculum, which is delivered as twelve, 30 minute weekly sessions incorporated into a team's usual work time activities. The curriculum is designed to build understanding, healthy decision making skills and engender the social support of teammates; its content and scope reflects the core lifestyles activities used with fire fighters and law enforcement, along with adaptations for the needs of Correctional Officers in domains of the team-building, family support and psychological health.

Participant assessments include established survey instruments, physiological measures and selected laboratory parameters of outcomes and potential mediating variables at the individual, interpersonal and organizational levels. Intervention delivery and fidelity will be assessed. Multilevel and latent growth modeling and mediation analyses will be used to assess outcomes and the relationships among variables. At proposal completion there will be an evidenced-based, exportable occupational safety and health program for COs. Its critical components will be defined, and its benefits clearly determined.

Study Type

Interventional

Enrollment (Actual)

86

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Oregon
      • Portland, Oregon, United States, 97239
        • Oregon Health and Science University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • security employee of a participating facility in the Oregon Department of Corrections

Exclusion Criteria:

  • none

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Testing Only
Experimental: Testing & Intervention
Intervention involves a scripted peer-taught interactive curriculum, which is delivered as twelve, 30 minute weekly sessions incorporated into a team's usual work time or overtime activities.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in BMI at 6 and 12 months
Time Frame: Baseline, 6 months, 12 months
calculation of direct measurement of height and weight
Baseline, 6 months, 12 months
Change from baseline in Fruit and Vegetable Intake at 6 and 12 months
Time Frame: Baseline, 6 months, 12 months
questionnaire, NCI fruit/vegetables (Thompson et al., 2002)
Baseline, 6 months, 12 months
Change from baseline in Physical Activity at 6 and 12 months
Time Frame: Baseline, 6 months, 12 months
questionnaire; Elliot et al., 2007
Baseline, 6 months, 12 months
Change from baseline in Stress at 6 and 12 months
Time Frame: Baseline, 6 months, 12 months
questionnaire; Netemeyer RG et al, 1996; Cohen et al., 1983; Stanton et al, 2001
Baseline, 6 months, 12 months
Change from baseline in Sleep at 6 and 12 months
Time Frame: Baseline, 6 months, 12 months
questionnaire; Sorenson et al., 2011; Buysee et al., 1989; Buxton et al.; Rajaratnam et al., 2011
Baseline, 6 months, 12 months
Change from baseline in Alcohol Use at 6 and 12 months
Time Frame: Baseline, 6 months, 12 months
questionnaire
Baseline, 6 months, 12 months
Change from baseline in Tobacco Use at 6 and 12 months
Time Frame: Baseline, 6 months, 12 months
questionnaire; study specific development
Baseline, 6 months, 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in Blood Pressure at 6 and 12 months
Time Frame: Baseline, 6 months, 12 months
direct measurement
Baseline, 6 months, 12 months
Change from baseline in Percent Body Fat at 6 and 12 months
Time Frame: Baseline, 6 months, 12 months
direct measurement via Bioelectric Impedance Analysis scale
Baseline, 6 months, 12 months
Change from baseline in Lipids and Lipoproteins at 6 and 12 months
Time Frame: Baseline, 6 months, 12 months
direct measurement via Cholestech LDX analyzer
Baseline, 6 months, 12 months
Change from baseline in Glucose at 6 and 12 months
Time Frame: Baseline, 6 months, 12 months
direct measurement via Cholestech LDX analyzer
Baseline, 6 months, 12 months
Cost-Effective Analysis
Time Frame: 12 months
analysis of departmental aggregate data of injury rates and workers compensation claims
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kerry S Kuehl, MD, DrPH, Oregon Health and Science University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (Actual)

August 1, 2014

Study Completion (Actual)

September 1, 2014

Study Registration Dates

First Submitted

October 7, 2013

First Submitted That Met QC Criteria

March 27, 2014

First Posted (Estimate)

March 28, 2014

Study Record Updates

Last Update Posted (Estimate)

October 30, 2015

Last Update Submitted That Met QC Criteria

October 28, 2015

Last Verified

October 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • e7925
  • U19OH010154 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Activity

Clinical Trials on Testing & Intervention

3
Subscribe